FDA limits COVID-19 vaccine approvals to elderly and high-risk groups, but millions still eligible

(NaturalNews) The U.S. Food and Drug Administration (FDA) will now restrict COVID-19 vaccine approvals primarily to high-risk groups (65+, immunocompromised and…